Lorenzo
Monserrat Iglesias
Azienda Ospedaliero-Universitaria Careggi
Florencia, ItaliaPublicacións en colaboración con investigadores/as de Azienda Ospedaliero-Universitaria Careggi (8)
2022
-
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198
2021
-
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105
-
Prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy
Journal of Clinical Medicine, Vol. 10, Núm. 7
2020
-
Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis
Journal of the American College of Cardiology, Vol. 76, Núm. 2, pp. 186-197
-
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry
Circulation: Genomic and Precision Medicine, Vol. 13, Núm. 6, pp. E003117
2016
-
European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology
European Heart Journal, Vol. 37, Núm. 2, pp. 164-173
-
Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry
International Journal of Cardiology, Vol. 219, pp. 331-338
2003
-
Hypertrophic cardiomyopathy and outflow tract obstruction [4] (multiple letters)
New England Journal of Medicine